Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells.
D000818:Animals; D005971:Glutamates; D006624:Hippocampus / Q000187:drug effects* / Q000473:pathology; D007276:Injections, Intraventricular; D007608:Kainic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D011712:Pyramidal Tracts / Q000187:drug effects* / Q000473:pathology; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012640:Seizures / Q000139:chemically induced
D005971:Glutamates; D011759:Pyrrolidines; D011955:Receptors, Drug; D007608:Kainic Acid